André Nicolas Selected Research

Integrins

1/2013

New blocking antibodies impede adhesion, migration and survival of ovarian cancer cells, highlighting MFGE8 as a potential therapeutic target of human ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André Nicolas Research Topics

Disease

26	Neoplasms (Cancer) 03/2022 - 03/2006
15	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2006
8	Neoplasm Metastasis (Metastasis) 11/2022 - 12/2014
4	Uveal melanoma 11/2022 - 12/2014
3	Triple Negative Breast Neoplasms 01/2022 - 01/2015
3	Ovarian Neoplasms (Ovarian Cancer) 12/2017 - 01/2013
2	Squamous Cell Carcinoma of Head and Neck 08/2021 - 07/2016
2	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 01/2020
2	Retinoblastoma (Glioblastoma, Retinal) 01/2021 - 09/2016
2	Carcinogenesis 12/2016 - 11/2011
2	Carcinoma (Carcinomatosis) 01/2013 - 08/2011
1	Melanoma (Melanoma, Malignant) 11/2022
1	Chordoma 03/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2021
1	Adenocarcinoma 04/2021
1	Acidosis 04/2021
1	Ovarian Epithelial Carcinoma 04/2021
1	Adenomyoepithelioma 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Bloom Syndrome 01/2017
1	Retinal Neoplasms 09/2016
1	Inflammation (Inflammations) 07/2016
1	Neuroblastoma 05/2014
1	Fibroadenoma 03/2006
1	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2006

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2006
6	Messenger RNA (mRNA)IBA 04/2021 - 03/2006
4	Biological ProductsIBA 03/2022 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 10/2009
3	Hormones (Hormone)IBA 04/2021 - 01/2015
3	Monoclonal AntibodiesIBA 01/2013 - 03/2006
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022 - 01/2019
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2019
2	Histones (Histone)IBA 01/2019 - 01/2015
2	CytokinesIBA 01/2019 - 07/2016
2	EnzymesIBA 01/2019 - 03/2006
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 11/2022
1	Laminin (Merosin)IBA 11/2022
1	Therapeutic UsesIBA 03/2022
1	tazemetostatIBA 03/2022
1	Carbonic Anhydrase IXIBA 04/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2021
1	dabrafenibIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	InterferonsIBA 01/2021
1	trametinibIBA 01/2021
1	methylamphotericin B (AME)IBA 01/2021
1	Piwi-Interacting RNAIBA 09/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	palbociclibIBA 01/2020
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	GSK3235025IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	aminoflavoneIBA 01/2017
1	Cytidine DeaminaseIBA 01/2017
1	Toll-Like Receptor 9IBA 12/2016
1	Pattern Recognition ReceptorsIBA 12/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2016
1	Bevacizumab (Avastin)FDA Link 09/2016
1	Carboplatin (JM8)FDA LinkGeneric 09/2016
1	LigandsIBA 07/2016
1	Thymic Stromal LymphopoietinIBA 07/2016
1	InterleukinsIBA 07/2016
1	Cetuximab (Erbitux)FDA Link 04/2015
1	Histone Deacetylase InhibitorsIBA 01/2015
1	Estrogen Receptor alphaIBA 01/2015
1	Estrogen ReceptorsIBA 01/2015
1	abexinostatIBA 01/2015
1	Everolimus FDA Link 12/2014
1	CrizotinibIBA 05/2014
1	vandetanib (ZD6474)IBA 05/2014
1	Anaplastic Lymphoma KinaseIBA 05/2014
1	enavatuzumabIBA 01/2014
1	TWEAK ReceptorIBA 01/2014
1	Blocking AntibodiesIBA 01/2013
1	IntegrinsIBA 01/2013
1	AntibodiesIBA 01/2013
1	AntioxidantsIBA 11/2011
1	MicroRNAs (MicroRNA)IBA 11/2011
1	Fc Receptors (Fc Receptor)IBA 08/2011
1	Immunoglobulin G (IgG)IBA 08/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2011
1	Tn antigenIBA 08/2011
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2009
1	Small Interfering RNA (siRNA)IBA 10/2009
1	Formaldehyde (Formol)FDA Link 03/2006
1	AntigensIBA 03/2006
1	AcetylgalactosamineIBA 03/2006

Therapy/Procedure

13	Therapeutics 01/2022 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
2	Immunotherapy 01/2020 - 08/2011
1	Transplantation 03/2022
1	Radiotherapy 09/2016